Pure Global
NCT05937074

Metabolic Response to Food in Advanced Lung Cancer

Pennington Biomedical Research Center·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Carcinoma, Non-Small-Cell Lung
Drug/Device/Intervention
Weight loss (%)
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Pennington Biomedical Research Center
Location
Baton Rouge, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jul 18, 2023
End date
Jun 30, 2025
Enrollment
12 participants
Primary outcome

Respiratory quotient

Summary

This goal of this study is to describe how unintentional weight loss influences fasting and
 post-prandial metabolic flexibility in participants with advanced non-small cell lung cancer.

ICD-10 classifications
Carcinoma in situ: Bronchus and lungSecondary malignant neoplasm of lungMalignant neoplasm: Lower lobe, bronchus or lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm of bronchus and lung
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05937074
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05937074 through Pure Global AI's free database. This phase not specified trial is sponsored by Pennington Biomedical Research Center and is currently Recruiting. The study focuses on Carcinoma, Non-Small-Cell Lung. Target enrollment is 12 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.